Titan Medical Inc (TMDIF)

[SPORT19]

From the article:

In addi on, even with all of the repower that Verb’s founders bring to the table, Huennekens says the company is posi oning its pla orm as an open system and is willing to consider collabora ons, either through acquisi on or some kind of licensing arrangement, with other start-ups developing novel technologies. Those might include sur- gical tools conven onally-described and apps that enable some more high tech-oriented capabili es. Huennekens says he can envision a scenario where, in a narrow market of, say, 20,000 annual procedures, Verb might not iden fy the opportunity as a high priority, but another company comes along with a tool necessary to do that procedure. “Will we nd a way to make sure that tool can work on our pla orm?” he asks. “Absolutely.” Surgery 4.0 Asked if J&J considered any partners other than Alpha- bet/Verily in launching its robo c program, Michael Del Prado notes that poten al partnerships are “something we look at constantly everywhere. Verily is a terri c partner in this venture.” But like Huennekens, Del Prado goes on to say that Ethicon, too, won’t object to bringing other companies onto the pla orm, if the opportunity is there, especially if the technologies those companies bring are “outside [Ethi- con’s] core capabili es.” Says Del Prado, “This is a complex project that will require a lot of other partners to bring it to frui on.” Even with Ethicon’s already large footprint in the OR and its history of driving innova on in surgery, he believes bringing other companies into the mix “will drive a lot of value for our customers.”